JP2018168171A5 - - Google Patents

Download PDF

Info

Publication number
JP2018168171A5
JP2018168171A5 JP2018117808A JP2018117808A JP2018168171A5 JP 2018168171 A5 JP2018168171 A5 JP 2018168171A5 JP 2018117808 A JP2018117808 A JP 2018117808A JP 2018117808 A JP2018117808 A JP 2018117808A JP 2018168171 A5 JP2018168171 A5 JP 2018168171A5
Authority
JP
Japan
Prior art keywords
compound
following structure
following
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018117808A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018168171A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018168171A publication Critical patent/JP2018168171A/ja
Publication of JP2018168171A5 publication Critical patent/JP2018168171A5/ja
Pending legal-status Critical Current

Links

JP2018117808A 2013-03-15 2018-06-21 スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法 Pending JP2018168171A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361801641P 2013-03-15 2013-03-15
US61/801,641 2013-03-15
EP13306056 2013-07-23
EP13306056.6 2013-07-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015562366A Division JP6438417B2 (ja) 2013-03-15 2014-03-14 スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法

Publications (2)

Publication Number Publication Date
JP2018168171A JP2018168171A (ja) 2018-11-01
JP2018168171A5 true JP2018168171A5 (OSRAM) 2019-01-17

Family

ID=51538203

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015562366A Active JP6438417B2 (ja) 2013-03-15 2014-03-14 スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法
JP2018117808A Pending JP2018168171A (ja) 2013-03-15 2018-06-21 スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2015562366A Active JP6438417B2 (ja) 2013-03-15 2014-03-14 スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法

Country Status (16)

Country Link
US (3) US20140316154A1 (OSRAM)
EP (3) EP3363805B1 (OSRAM)
JP (2) JP6438417B2 (OSRAM)
KR (1) KR20150132188A (OSRAM)
CN (1) CN105051051B (OSRAM)
AU (2) AU2014229638B2 (OSRAM)
BR (1) BR112015023558A2 (OSRAM)
CA (1) CA2900902C (OSRAM)
DK (1) DK3363805T3 (OSRAM)
ES (1) ES3017659T3 (OSRAM)
HK (1) HK1214266A1 (OSRAM)
MX (1) MX387128B (OSRAM)
PH (1) PH12015501835A1 (OSRAM)
SG (2) SG11201506456VA (OSRAM)
WO (1) WO2014140787A2 (OSRAM)
ZA (1) ZA201505860B (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102395375B (zh) 2009-02-16 2015-01-14 塞伦尼斯医疗控股有限公司 载脂蛋白a-i模拟物
HUE034637T2 (en) 2010-10-18 2018-02-28 Cerenis Therapeutics Holding Sa Compounds, compositions and methods for mobilizing cholesterol
BR112015023558A2 (pt) * 2013-03-15 2017-07-18 Cerenis Therapeutics Holding Sa métodos para a síntese de esfingomielinas e dihidroesfingomielinas
US9708354B2 (en) 2013-03-15 2017-07-18 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
EP3668549B1 (en) 2017-08-10 2024-05-15 Abionyx Pharma SA Apomers
WO2019030574A1 (en) 2017-08-10 2019-02-14 Cerenis Therapeutics Holding Cargomers
CN111757886A (zh) * 2018-03-27 2020-10-09 日油株式会社 鞘磷脂衍生的脂质及其生产方法
JP7303618B2 (ja) * 2018-10-05 2023-07-05 日本精化株式会社 スフィンゴリン脂質前駆体及びその製造方法、並びに、スフィンゴリン脂質の製造方法
US11752163B2 (en) 2020-04-16 2023-09-12 Abionyx Pharma Sa CER-001 therapy for treating kidney disease
IL297336A (en) 2020-04-16 2022-12-01 Abionyx Pharma Sa Methods for treating acute conditions using lipid binding protein-based complexes
WO2021209808A1 (en) 2020-04-16 2021-10-21 Abionyx Pharma Sa Cer-001 therapy for treating kidney disease
CN116322646A (zh) 2020-10-01 2023-06-23 阿比奥尼克斯制药公司 用于治疗眼病的包含基于脂质结合蛋白的复合物的组合物
IL307670A (en) 2021-04-15 2023-12-01 Abionyx Pharma Sa Use of lipid binding protein-based complexes in organ preservation solutions
AU2023250345A1 (en) 2022-04-06 2024-11-14 Abionyx Pharma Sa Methods for treating eye diseases using lipid binding protein-based complexes
WO2023194798A1 (en) 2022-04-06 2023-10-12 Abionyx Pharma Sa Methods for treating leukocytosis, endothelial dysfunction and carditis using lipid binding protein-based complexes
CN120344255A (zh) 2022-06-10 2025-07-18 阿比奥尼克斯制药公司 使用基于脂质结合蛋白的复合物治疗过度炎性病症的方法
AU2023284357A1 (en) 2022-06-10 2025-01-23 Abionyx Pharma Sa Methods for treating acute conditions using lipid binding protein-based complexes
CA3260759A1 (en) 2022-06-28 2024-01-04 Abionyx Pharma Sa SPHINGOMYELIN COMPOUNDS AND SYNTHETIC PROCESSES
AU2024207875A1 (en) 2023-01-13 2025-07-24 Abionyx Pharma Sa Lipid binding protein molecule therapy
WO2025093929A1 (en) 2023-10-31 2025-05-08 Abionyx Pharma Sa Lipid binding protein molecule therapy

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0146810A3 (de) 1983-12-05 1987-05-13 Solco Basel AG Verfahren zur Herstellung von Sphingosinderivaten
US5220043A (en) * 1991-03-21 1993-06-15 Ohio University Synthesis of D-erythro-sphingomyelins
US5766627A (en) 1993-11-16 1998-06-16 Depotech Multivescular liposomes with controlled release of encapsulated biologically active substances
DK0729351T3 (da) 1993-11-16 2000-10-16 Skyepharma Inc Vesikler med reguleret afgivelse af aktivstoffer
CA2320117A1 (en) 1998-02-12 1999-08-19 Emory University Sphingolipid derivatives and their methods of use
JP2004002215A (ja) * 2002-05-23 2004-01-08 National Institute Of Advanced Industrial & Technology スフィンゴ脂質誘導体の製造方法
AU2005205245A1 (en) 2004-01-15 2005-07-28 Biolab Ltd. Sphingomyelin, intermediates thereof and methods for preparation of same
EP1750673B1 (en) 2004-05-17 2009-12-02 Tekmira Pharmaceuticals Corporation Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
US7629385B2 (en) 2004-06-29 2009-12-08 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Sphingolipid-derived pharmaceutical compositions
JP4825947B2 (ja) 2004-08-04 2011-11-30 学校法人関西学院 不飽和アミノジオール類の製造方法
JP2006045113A (ja) 2004-08-04 2006-02-16 Kemikurea:Kk リン酸エステル類
US8206750B2 (en) 2005-03-24 2012-06-26 Cerenis Therapeutics Holding S.A. Charged lipoprotein complexes and their uses
US7470664B2 (en) * 2005-07-20 2008-12-30 Merck & Co., Inc. HCV NS3 protease inhibitors
JP2007204384A (ja) 2006-01-31 2007-08-16 Kemikurea:Kk 光学活性リン酸誘導体およびこれを用いた光学活性スフィンゴシン1−リン酸誘導体の製造方法
JP5429734B2 (ja) * 2007-02-09 2014-02-26 国立大学法人岐阜大学 スフィンゴ糖脂質の合成法
JP5178707B2 (ja) 2007-03-09 2013-04-10 株式会社糖鎖工学研究所 スフィンゴシン化合物、その製造方法及びスフィンゴミエリナーゼ阻害剤
WO2010041255A2 (en) 2008-10-07 2010-04-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Liposomal systems comprising sphingomyelin
ES2717455T3 (es) 2011-02-07 2019-06-21 Cerenis Therapeutics Holding Sa Complejos de lipoproteínas y fabricación y usos de los mismos
FR3000959B1 (fr) * 2013-01-14 2015-08-21 Holis Technologies Nouveaux intermediaires de synthese permettant d'acceder avec de bons rendements a des derives de sphingosines, ceramides et sphingomyelines
US9708354B2 (en) 2013-03-15 2017-07-18 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
BR112015023558A2 (pt) 2013-03-15 2017-07-18 Cerenis Therapeutics Holding Sa métodos para a síntese de esfingomielinas e dihidroesfingomielinas

Similar Documents

Publication Publication Date Title
JP2018168171A5 (OSRAM)
JP2021020948A5 (OSRAM)
JP2017008120A5 (OSRAM)
JP2018024670A5 (OSRAM)
JP2019089762A5 (OSRAM)
JP2020515557A5 (OSRAM)
JP2018150298A5 (OSRAM)
JP2020040981A5 (OSRAM)
JP2020007340A5 (OSRAM)
JP2019194236A5 (OSRAM)
JP2020534795A5 (OSRAM)
JP2019068846A5 (OSRAM)
JP2019124943A5 (OSRAM)
JP2018521020A5 (OSRAM)
JP2010019854A5 (OSRAM)
JP2018030858A5 (OSRAM)
JP2019164961A5 (OSRAM)
JP2021503553A5 (OSRAM)
JP2021502338A5 (OSRAM)
JP2018116258A5 (OSRAM)
JP2018186811A5 (OSRAM)
JP2021163968A5 (OSRAM)
JP2018162319A5 (OSRAM)
JP2019081810A5 (OSRAM)
JP2020049413A5 (OSRAM)